article thumbnail

The Ethical Challenges for Pharmaceutical Marketers in Using AI to Write Marketing Copy or Creative

Pharma Marketing Network

While AI can be a powerful tool for creating effective marketing campaigns, it also poses significant ethical challenges. One of the main ethical concerns with using AI in pharmaceutical marketing is the potential for the technology to perpetuate biases and discrimination. “The ethics of artificial intelligence.”

Ethics 52
article thumbnail

Data integrity considerations in Pharma and Life Sciences

European Pharmaceutical Review

Life science companies are increasingly using advanced technologies like artificial intelligence (AI), machine learning (ML) and blockchain to improve data quality and integrity by detecting anomalies in data and establishing tamper-proof audit trails for all data-related activities Data governance.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Getting Creative with Sustainability | How Pharma Engages

Pharma Marketing Network

Companies are invited to reapply each year to be evaluated based on how their policies, actions, and results are impacting the environment, ethics, labor and human rights, and sustainable procurement. And last, but certainly not least—governance. Ethics is a skill.” Why make it inviting? What’s Next? Track, measure, and improve.

Pharma 103
article thumbnail

Strengthening and transforming the pharmaceutical supply chain

European Pharmaceutical Review

Yammahi was instrumental in building Hayat’s extensive distribution network needed to supply vaccines during the COVID-19 pandemic. The significant challenges, here, lie in effectively managing the complexity and coordination among diverse interconnected networks, particularly when operating across countries with varying regulations.

article thumbnail

Why Is FDA Issuing Fewer Marketing Violation Letters?

Pharma Marketing Network

Resource Constraints: The FDA operates within a dynamic regulatory environment and faces resource constraints like any other government agency. appeared first on Pharma Marketing Network. The post Why Is FDA Issuing Fewer Marketing Violation Letters?

article thumbnail

Revolutionizing Rare Disease Research: Unleashing the Power of Patient Advocacy and Artificial Intelligence

PM360

Their impact extends beyond increasing participant numbers, encompassing broader contributions to research design, ethics, and addressing logistical barriers 2. Crucially, improved accessibility to collaborative research and advocacy networks is vital.

article thumbnail

Entry-Level Pharma Sales: It's More Than Just a Job Search (Here's Why)

Contrarian Sales Techniques

Network and build connections Attend industry events: Participate in conferences, workshops, or career fairs related to the pharmaceutical industry to establish connections and gain insights. Reach out to your network: Inform your personal and professional network about your job search and inquire about potential leads or introductions.

Sales 52